These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6196550)

  • 1. A potent noncompetitive angiotensin II antagonist induces only competitive inhibition of angiotensin III responses.
    Trachte GJ; Peach MJ
    J Cardiovasc Pharmacol; 1983; 5(6):1025-33. PubMed ID: 6196550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ selective angiotensin antagonists: sarcosyl1-cysteinyl(S-methyl)8-angiotensin I.
    Freer RJ; Sutherland JC; Day AR
    Eur J Pharmacol; 1980 Aug; 65(4):349-54. PubMed ID: 7408944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of different contractile mechanisms for angiotensin II and des-Asp1-angiotensin II in rabbit aortic strips.
    Ackerly JA; Moore AF; Peach MJ
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5725-8. PubMed ID: 271997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile responses of isolated dog mesenteric arteries to angiotensin I, II and III.
    Toda N; Hayashi S; Miyazaki M
    Jpn J Pharmacol; 1978 Aug; 28(4):527-34. PubMed ID: 732038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacology of a noncompetitive antagonist of angiotensin-induced contractions of vascular smooth muscle. [Sarcosyl]1-[cysteinyl (s-methyl)]8-angiotensin II.
    Freer RJ; Sutherland JC; Day AR
    Circ Res; 1980 May; 46(5):720-5. PubMed ID: 7363420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics and vascular effects of various angiotensin II antagonists.
    Criscione L; Thomann H; Whitebread S; de Gasparo M; Bühlmayer P; Herold P; Ostermayer F; Kamber B
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S56-9. PubMed ID: 1705629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin III-induced modulation of neurogenic responses in the rabbit vas deferens and portal vein.
    Trachte GJ; Sybertz EJ; Michener M; Binder SB; Peach MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):327-33. PubMed ID: 6090959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin.
    Scanlon MN; Moore GJ
    Pharmacology; 1988; 37(3):137-47. PubMed ID: 3227047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature sensitivity of angiotensin-induced inotropic effects.
    Trachte GJ; Peach MJ
    Proc Soc Exp Biol Med; 1984 Oct; 177(1):47-54. PubMed ID: 6473355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for analyzing and interpreting cooperativity in dose-response curves--I. Antagonist effects on angiotensin receptors in smooth muscle.
    Moore GJ; Scanlon MN
    Gen Pharmacol; 1989; 20(2):193-8. PubMed ID: 2714616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta.
    Brailoiu E; Filipeanu CM; Tica A; Toma CP; de Zeeuw D; Nelemans SA
    Br J Pharmacol; 1999 Mar; 126(5):1133-8. PubMed ID: 10205000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sar1Ile7]angiotensin III, a new selective antagonist of the pressor effect of angiotensin III in conscious rats.
    Tabrizchi R; Moore GJ; Pang CC
    Life Sci; 1988; 43(6):537-43. PubMed ID: 3405034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
    Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
    J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of des-Asp-angiotensin I on the contractile action of angiotensin II and angiotensin III.
    Sim MK; Yuan HT
    Eur J Pharmacol; 1995 May; 278(2):175-8. PubMed ID: 7672002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings.
    Criscione L; Thomann H; Whitebread S; de Gasparo M; Kamber B
    Biochem Biophys Res Commun; 1990 Jun; 169(2):636-42. PubMed ID: 2357223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta using a slowly dissociating antagonist [Sar1,Ile8]ANG II for receptor blockade.
    Scanlon MN; Moore GJ
    J Pharmacol Methods; 1988 Nov; 20(3):207-24. PubMed ID: 3236889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin III binding in the rat adrenal glomerulosa.
    Douglas JG; Khosla MC; Bumpus FM
    Endocrinology; 1985 Apr; 116(4):1598-602. PubMed ID: 3971929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal modulation of the binding of angiotensin agonists and antagonists to angiotensin receptors in smooth muscle.
    Koziarz P; Beck J; Moore GJ
    Gen Pharmacol; 1993 May; 24(3):705-13. PubMed ID: 8365653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.